Anbieter: Books From California, Simi Valley, CA, USA
paperback. Zustand: Fine.
Anbieter: Books From California, Simi Valley, CA, USA
paperback. Zustand: Very Good. Cover and edges may have some wear.
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 25,31
Anzahl: 2 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 26,95
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 244 pages. 6.10x0.60x9.10 inches. In Stock.
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. 2025. paperback. . . . . . Books ship from the US and Ireland.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 46,18
Anzahl: 1 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 244 pages. 6.10x0.60x9.10 inches. In Stock.
Sprache: Englisch
Verlag: National Academies Press Sep 2025, 2025
ISBN 10: 0309993822 ISBN 13: 9780309993821
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - The United States is a global leader in biomedical research, generating therapeutic breakthroughs that advance the health of the nation and the world. The public and private sectors contribute to this advancement by funding biomedical research and development. The current level of investment in pharmaceutical development in the United States, while substantial, does not always yield desired health outcomes or meet the needs of patients. Public and private funders face a myriad of challenges that affect their funding decisions and hinder the ability of the drug development system to prioritize disease burden and unmet need - often leaving critical gaps in available treatment options.